期刊文献+

16826例妇科患者宫颈细胞超薄细胞检测分析

Analysis on 16 826 cases of TCT of cervix uteri
下载PDF
导出
摘要 [目的]通过对液基超薄细胞系统(TCT)的16826例标本结果分析,探讨宫颈癌的发病情况和筛查实验。[方法]利用妇科液基超薄细胞检测系统(TCT),对妇科子宫颈管刷取的细胞标本进行制片、固定、染色、显微镜检查;根据《子宫颈细胞学Bethesda报告系统》(TBS)判断标准,做出诊断。[结果]16826例标本中,发现1例鳞状细胞癌,占0.006%;2例CIN-3,占0.012%;12例CIN-2,占0.01%;391例CIN-1,占2.3%,其中263例为CIN-1HPV感染,占1.56%;有炎性反应性细胞改变的14410例,其中滴虫感染197例,占1.17%;霉菌感染388例,占2.3%;细菌感染156例,占0.9%;无上皮内病变或恶性瘤变的2001例,占11.2%;8例ASC-US占0.5%;1例AGUS,占0.006%。[结论]TCT和TBS系统能全面准确的反映宫颈病变情况。防止HPV感染,及时治疗及阻止CIN病变升级是防止宫颈癌和癌前病变的关键。 [Objective]To study and discuss carcinoma of cervix uteri by means of summarization and analysis based on 16826 subjects of TCT. [Methods]TCT was used to coat samples,fix,dye and microcheck based on the subject of the cell acquired from cervical canal;Diagonosis was made according to TBS. [Results]Among 16826 samples. 1 case of squamous cell carcinoma was found, accounting for 0. 006% ;2 cases of CIN-3, accounting for 0. 012 %;12 cases of CIN-2, accounting for 0. 01%;and 391 cases of CIN-1 were found, accounting for 2.3%;among them,263 were caese of CIN- 1HPV infection,accounting for 1.56%;197 cases of trichomonal infection, accounting for 1.17%;388 cases of candidal infection,accounting for 2.3 % ;156 cases of bacterial infection, accounting for 0.9% ;14 410 cases of inflammatory cell changing;2001 cases of cervical intraepithelial neoplasia, accounting for 11.2 % ; 8 cases of ASC-US, accounting for 0.5 % ; and 1 case of AGUS,accounting for 0. 006 %. [Conclusion]TCT and TBS can accurately and whollyreflect cervical lesion. In preventing HPV infection, curing and blocking the evolving of CIN is the key to preventing cervical cancer and precancer lesion.
作者 邹翠文
出处 《预防医学论坛》 2007年第11期1025-1026,1028,共3页 Preventive Medicine Tribune
关键词 TCT 宫颈癌 TBS诊断系统 HPV TCT carcinoma of cervix uteri TBS HPV
  • 相关文献

参考文献6

二级参考文献23

  • 1吴爱如.宫颈癌的早期诊断[J].中国肿瘤,1994,3(3):11-12. 被引量:8
  • 2Belinson J,Int J Gynecol Cancer,1999年,9卷,411页
  • 3Sheets E,J Gynecol Technol,1995年,1卷,27页
  • 4Parkin D M,Bray F,Ferlay J,et al.Estimating the world cancer burden:Globocan 2000[J].Int J Cancer,2001,94:153-156.
  • 5Franco,Eduardo L,Duarte F,et al.Cervical cancer:epidemiology,prevention and the role of human papillomavirus infection[ J ].Canadian Medical Association Journal,2001,164(7):1017-1025.
  • 6Torres L A,Rojo H G,Torres R A,et al.Cervical cancer:Current view of its epidemiology and risk factors[ J ].Gynecol Obstet Mex,2004,72:466-474.
  • 7Boyle P,Vecchia C,Walker A,et al.FIGO annual report on the results of treatment in gynecological Cancer[ J ].Journal of epidemiology and biostatictcs,2001,12:7-43.
  • 8Liu J,Rose B,Huang X,et al.Comparative analysis of characteristics of women with cervical cancer in high-versus low-incidence regions[ J].Gynecol Oncol,2004,94(3):803-810.
  • 9Nicolas F S,Andrea T,Eliane D F,et al.Viral load as a predictor of the risk of cervical intraepithelial neoplasia[ J].Int J Cancer,2003,103:519-524.
  • 10Silva D M,Eiben C L,Fausch S C,et al.Cervical cancer vaccines:emerging concepts and developments[ J ].Cell Physiol,2001,186(2):169-182.

共引文献2016

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部